Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera for Anemia in CKD Transitioning to Dialysis
NCT00454246Phase 3Terminated
- Sponsor
- Roche
- Start
- Apr 2007
- Primary completion
- Feb 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease (CKD-A), sponsored by Roche. Started Apr 2007; status: terminated.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00454246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454246.